APOL1 Gene: A Surprising Link to Hydrocephalus
Research connects APOL1 G1 variant to hydrocephalus and its effects on health.
Teruhiko Yoshida, Zhi-Hong Yang, Shinji Ashida, Zu Xi Yu, Shashi Shrivastav, Krishna Vamsi Rojulpote, Piroz Bahar, David Nguyen, Danielle A. Springer, Jeeva Munasinghe, Matthew F. Starost, Victoria J. Hoffmann, Avi Z. Rosenberg, Bibi Bielekova, Han Wen, Alan T. Remaley, Jeffrey B. Kopp
― 6 min read
Table of Contents
Kidney disease is a common problem, especially among individuals of sub-Saharan African ancestry. One major player in this arena is a gene called APOL1, with two main versions known as G1 and G2. You might think of these variants as little troublemakers that increase the chance of kidney issues, particularly chronic kidney disease (CKD). Around 13% of African Americans carry both of these risk variants, putting them at a significantly higher risk for CKD. But wait, there's more! It looks like these variants might also be linked to other health issues, including hydrocephalus and Cardiovascular Diseases.
The APOL1 Gene
APOL1 is a gene that makes a protein which is found in various parts of the body, including the kidneys and blood vessels. Interestingly, this protein also shows up in a specific group of particles called high-density lipoproteins, which are often considered "good" cholesterol. The more we look at APOL1, the more complicated it seems. Some studies suggest that having the G1 and G2 variants could even increase the risk of cardiovascular diseases, but the findings are mixed. Some research shows a link, while other studies say, “Not so fast!”
Hydrocephalus: A Mysterious Condition
Now, let's talk about hydrocephalus. This condition happens when fluid builds up in the brain, leading to swelling and pressure. It’s not just a rare occurrence; in fact, there are about 200,000 new cases every year in sub-Saharan Africa alone! That's a serious number, especially considering that the region has a high prevalence of the APOL1 high-risk variants. What's the connection? Well, scientists have been trying to figure that out.
In one study, researchers used a unique mouse model to investigate the role of the APOL1 G1 variant in hydrocephalus. These particular mice were bred to have a mix of the APOL1 variants and another gene known as ApoE, which has a history of being associated with atherosclerosis-a fancy term for the hardening of arteries. The outcome was surprising; while researchers weren't looking for hydrocephalus, they stumbled upon it!
The Research Process
The team took a pretty rigorous approach to their research, following all the necessary guidelines and protocols. They used specialized mice that carried the human APOL1 gene, specifically versions G0 and G1, and bred them with ApoE knock-out mice. The idea was to see if these genetic variations would lead to any noticeable differences in health outcomes.
Once the breeding was done, they carefully monitored the mice for any signs of trouble. There were some key signs to look out for, like "dome-shaped" heads-yep, that's one way to tell if a mouse has hydrocephalus! After a series of tests and examinations, the researchers were able to confirm the presence of hydrocephalus in a small percentage of the mice that carried the G1 variant.
What Did They Find?
The findings were intriguing. In the mouse model, a small portion of the subjects with the G1 variant developed hydrocephalus. This variant seems to trigger the choroid plexus-the part of the brain responsible for making Cerebrospinal Fluid (CSF)-to produce too much fluid. Imagine a water balloon that just keeps getting filled up until it bursts!
The research didn't stop there. They wanted to look even closer at the cells involved. Using advanced techniques, they conducted a single-cell RNA analysis of the choroid plexus tissue. They found that the cells were indeed expressing the APOL1 G1 protein, and also that there were changes in certain genes that regulate fluid production. This led to the idea that having the G1 variant activates pathways in these cells that result in overproduction of CSF, thus causing the fluid build-up associated with hydrocephalus.
MTORC2 Connection
TheSpeaking of pathways, there’s one called the mTORC2 pathway that came into play. This pathway is known for its role in cell growth and metabolism. In the context of APOL1 G1, it appears that this pathway gets activated, leading to the upregulation of transporters in the choroid plexus cells. These transporters are essential for handling fluids. When they are overactive, they could cause the brain to create excess CSF, contributing to hydrocephalus.
Links to Cardiovascular Diseases
Now, about cardiovascular diseases: The researchers were curious if the APOL1 variants were making the mice more likely to suffer from issues related to the heart or blood vessels. After all, the G1 variant seemed to have consequences in one area-could it be just as troublesome in another? They looked into this by examining various factors related to cardiac health, including cholesterol levels and atherosclerosis.
In their findings, they observed that there were no significant differences in the heart-related health of mice carrying the G1 variant compared to those with the G0 variant. Even when using different methods to assess cardiovascular issues, the results were pretty consistent. This suggested that while APOL1 G1 may stir things up in the brain leading to hydrocephalus, it doesn’t appear to exacerbate heart problems in the same way.
Human Implications
To take this research beyond the realm of mice, the team turned to the All of Us cohort, a significant health study that collects data from various participants. They investigated whether individuals with the APOL1 G1 variant had a higher prevalence of hydrocephalus in this larger group. The results were telling: individuals with this variant showed a higher prevalence rate compared to those without it. This adds a layer of evidence suggesting that the G1 variant doesn't just mess with mice; it could also have implications for human health!
Conclusion
So, what have we learned? The APOL1 G1 variant shows a compelling connection to hydrocephalus, which seems driven by an overactive mTORC2 pathway that leads to excessive fluid production in the brain. Meanwhile, its impact on cardiovascular health seems more limited.
As funny as it sounds, we've got a gene that likes to keep things interesting, shaking hands with both kidney issues and hydrocephalus in some individuals. The more we uncover about these variants, the clearer it becomes that our genes can take us down unexpected paths. Who knew a little protein could lead to such big headlines?
Future Directions
While this research has shed light on the connection between APOL1 G1 and hydrocephalus, it's clear there's still more to explore. Scientists will need to keep digging to understand all the mechanisms at work here, especially when considering environmental influences and their interplay with genetics. The ultimate goal is to improve outcomes for individuals affected by these variants, and perhaps even bring a little humor to the complex world of genetics along the way!
Title: Apolipoprotein-L1 G1 variant contributes to hydrocephalus but not to atherosclerosis in apolipoprotein-E knock-out mice
Abstract: IntroductionIn USA, six million individuals with Sub-Saharan ancestry carry two APOL1 high-risk variants, which increase the risk for kidney diseases. Whether APOL1 high-risk variants are independent risk factors for cardiovascular diseases is unclear and requires further investigation. MethodsWe characterized a mouse model to investigate the role of APOL1 in dyslipidemia and cardiovascular diseases. Transgenic mice carrying APOL1 (G0 and G1 variants) on bacterial artificial chromosomes (BAC/APOL1 mice) were crossed with the ApoE knock-out (ApoE-KO) atherosclerosis mouse model. The compound transgenic mice were evaluated for the impact of APOL1 on systemic phenotypes. ResultsApoE-KO mice carrying APOL1-G0 and APOL1-G1 did not show differences in the extent of atherosclerotic lesions or aortic calcification, as evaluated by Sudan IV staining and radiographic examination, respectively. However, [~]20% of ApoE-KO; BAC/APOL1-G1 mice developed hydrocephalus and required euthanasia. The hydrocephalus was communicating and likely was due to excess cerebrospinal fluid produced by the choroid plexus, where epithelial cells expressed APOL1. Single-nuclear RNA-seq of choroid plexus identified solute transporter upregulation and mTORC2 pathway activation in APOL1-G1-expressing epithelial cells. Further, in the All of Us cohort, we found higher hydrocephalus prevalence among individuals with the APOL1-G1 variant in both recessive and dominant models, supporting the mouse findings. ConclusionWhile APOL1-G1 expression in ApoE-KO mice did not worsen cardiovascular disease phenotypes, we uncovered hydrocephalus as a novel APOL1 risk allele-mediated phenotype. These findings extend the spectrum of APOL1-associated pathologies.
Authors: Teruhiko Yoshida, Zhi-Hong Yang, Shinji Ashida, Zu Xi Yu, Shashi Shrivastav, Krishna Vamsi Rojulpote, Piroz Bahar, David Nguyen, Danielle A. Springer, Jeeva Munasinghe, Matthew F. Starost, Victoria J. Hoffmann, Avi Z. Rosenberg, Bibi Bielekova, Han Wen, Alan T. Remaley, Jeffrey B. Kopp
Last Update: Dec 28, 2024
Language: English
Source URL: https://www.biorxiv.org/content/10.1101/2024.12.28.630625
Source PDF: https://www.biorxiv.org/content/10.1101/2024.12.28.630625.full.pdf
Licence: https://creativecommons.org/publicdomain/zero/1.0/
Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.
Thank you to biorxiv for use of its open access interoperability.